Tulip Thomas H. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Sep 14, 2012
Insider Transaction Report
Form 4
Tulip Thomas H.
Other
Transactions
- Purchase
Common Stock
2012-09-14$2.70/sh+15,000$40,500→ 27,500 total
Holdings
- 940(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $2.66 to $2.72. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.
- [F2]Total includes shares acquired under the Neoprobe Corporation 401(k) Plan.